ADMS Shares Outstanding History
Below is a table of the ADMS shares outstanding history going back to 4/9/2014:

Date ADMS Shares Outstanding

Also see: ADMS Market Cap History
ADMS Historical Shares Outstanding:
+8.98% CAGR
ADMS Historical Shares Outstanding: +8.98% CAGR

Mouse over chart for data details
4/9/2014 ...7/31/2020
Adamas Pharmaceuticals focuses on therapies to reduce the burden of neurological diseases on patients, caregivers, and society. Co.'s product, GOCOVRI™ (amantadine) extended-release capsules, is for the treatment of dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications. Co.'s partnered product, Namzaric® (memantine hydrochloride extended release and donepezil hydrochloride) capsules, are for the treatment of moderate to severe dementia of an Alzheimer's type, marketed in the U.S. by Allergan plc under a license agreement between Co. and Forest Laboratories Holdings Limited, a subsidiary of Allergan plc. We show 28 historical shares outstanding datapoints in our coverage of ADMS's shares outstanding history.

Understanding the changing numbers of ADMS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADMS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADMS by allowing them to research ADMS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ADMS:
ADMS SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adamas Pharmaceuticals (ADMS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ADPT Shares Outstanding History
ADRO Shares Outstanding History
ADUS Shares Outstanding History
ADVM Shares Outstanding History
ADXS Shares Outstanding History
AEMD Shares Outstanding History
AERI Shares Outstanding History
AEZS Shares Outstanding History
AGEN Shares Outstanding History
AGIO Shares Outstanding History
More Healthcare companies »


ADMS Shares Outstanding History | | Copyright © 2017 - 2020, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.